dc.contributor.author | Desser, Arna S. | |
dc.contributor.author | Ringerike, Tove | |
dc.contributor.author | Klemp, Marianne | |
dc.date.accessioned | 2018-01-16T19:13:12Z | |
dc.date.available | 2018-01-16T19:13:12Z | |
dc.date.created | 2015-01-09T13:10:08Z | |
dc.date.issued | 2014 | |
dc.identifier.isbn | 978-82-8121-855-0 | |
dc.identifier.uri | http://hdl.handle.net/11250/2477857 | |
dc.language.iso | eng | |
dc.publisher | Norwegian Knowledge Centre for the Health Services | |
dc.relation.ispartof | Rapport fra Kunnskapssenteret | |
dc.relation.ispartofseries | Rapport fra Kunnskapssenteret | |
dc.subject.mesh | Diabetes Mellitus, Type 2 | |
dc.subject.mesh | Metformin | |
dc.subject.mesh | Sulfonylurea Compounds | |
dc.subject.mesh | Dipeptidyl-Peptidase IV Inhibitors | |
dc.subject.mesh | Glucagon-Like Peptide 1 | |
dc.subject.mesh | Drug Utilization | |
dc.title | Effect of new anti-diabetic medications in combination with metformin compared to sulfonylurea in combination with metformin in patients with type 2 diabetes | |
dc.type | Research report | |
dc.description.version | publishedVersion | |
dc.source.pagenumber | 54 | |
dc.source.volume | 2014 | |
dc.source.issue | 9 | |
dc.identifier.cristin | 1194087 | |
cristin.unitcode | 7502,7,2,5 | |
cristin.unitcode | 7502,0,0,0 | |
cristin.unitname | Legemidler og helseøkonomi | |
cristin.unitname | Folkehelseinstituttet | |
cristin.ispublished | true | |
cristin.fulltext | original | |